Details for New Drug Application (NDA): 208539
The generic ingredient in TICAGRELOR is ticagrelor. There is one drug master file entry for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the ticagrelor profile page.
Summary for 208539
| Tradename: | TICAGRELOR |
| Applicant: | Micro Labs |
| Ingredient: | ticagrelor |
| Patents: | 0 |
Pharmacology for NDA: 208539
| Mechanism of Action | Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors P2Y12 Receptor Antagonists |
| Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 208539
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TICAGRELOR | ticagrelor | TABLET;ORAL | 208539 | ANDA | Micro Labs Limited | 42571-263 | 42571-263-05 | 500 TABLET, FILM COATED in 1 BOTTLE (42571-263-05) |
| TICAGRELOR | ticagrelor | TABLET;ORAL | 208539 | ANDA | Micro Labs Limited | 42571-263 | 42571-263-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42571-263-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
| Approval Date: | Apr 27, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 90MG | ||||
| Approval Date: | Apr 27, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
